For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...

A new national survey has revealed alarming gaps in women’s awareness of free screenings and Medicare rebates. From Medicare-rebated menopause assessments to self-collected cervical screening and ...

MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...

If your Medicare Advantage plan is being terminated, you'll receive a notice. If you don't select another plan, you'll be enrolled in traditional Medicare by default. Seniors can either stick with ...

Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. If you watched the Super Bowl, you ...

Coverage of high-cost drugs selected for Medicare price negotiation has improved under the Inflation Reduction Act, according to an analysis from KFF. All Medicare Part D enrollees now have coverage ...

Personalis, Inc. PSNL stock is up in Tuesday’s premarket session after the company received Medicare coverage for its NeXT Personal molecular residual disease test for lung cancer surveillance. This ...

NEW YORK – Personalis announced on Tuesday that its NeXT Personal molecular residual disease test has received coverage from the US Centers for Medicare and Medicaid Services for surveillance of ...

The Food and Drug Administration recently approved the IsoPSA blood test, which was developed by Cleveland Diagnostics, a Cleveland Clinic Innovations portfolio company, which looks for specific ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today celebrated the passage of landmark federal legislation that ...

Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...

Eli Lilly CEO Dave Ricks said upcoming Medicare coverage of obesity drugs could be a major catalyst for the launch of the company's closely watched experimental obesity pill, orforglipron. The launch ...